• Rapid Dose Therapeutics plans to pay Sept. 30, 2026 quarterly interest on its secured convertible notes in common shares.
• 1,092,821 shares expected by Oct. 15 at a deemed price of $0.13 to settle $142,067.63 of accrued interest.
• Notes carry 18% interest, compounded monthly, with interest payable quarterly in shares priced at the quarter-end CSE close.
• Maturity on extended notes is Nov. 30, 2026; the company can prepay with 10 days’ notice.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapid Dose Therapeutics Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610050837NEWSFILECNPR____20261005_317389_1) on October 05, 2026, and is solely responsible for the information contained therein.